What's new

Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 25, Status: Authorised

May 6, 2025 - 08:05
 0
Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Courtesy Rides by Bolt for Business Embrace the Peak-End Rule of Guest Satisfaction

Next Article

Hugo Boss revenue and profit dips in Q1

Related Posts

Human medicines European public assessment report (EPAR): Levetiracetam Sun, levetiracetam, Date of authorisation: 14/12/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 29, 2025  0

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0